Try

Celcuity Inc.

CELCUnited States

23 filed reports · 313 financial concepts · 0 earnings calls · 0 media appearances

Filed reports

23 reports · Jun 2021 to Jun 2026

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR161,844Jun 2021 to Jun 2026
Annual · 10-KSEC EDGAR51,467Dec 2021 to Dec 2025
Annual · 10-K/ASEC EDGAR11Dec 2022
Current · 8-KSEC EDGAR15Jun 2026

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q210-QJun 30, 2026Aug 13, 2026237Open
FY2026 Q28-KJun 30, 2026Aug 13, 20265Open
FY2026 Q110-QMar 31, 2026May 14, 2026164Open
FY202510-KDec 31, 2025Mar 26, 2026408Open
FY2025 Q310-QSep 30, 2025Nov 13, 2025149Open
FY2025 Q210-QJun 30, 2025Aug 14, 202583Open
FY2025 Q110-QMar 31, 2025May 15, 202597Open
FY202410-KDec 31, 2024Mar 31, 2025274Open
FY2024 Q310-QSep 30, 2024Nov 14, 2024108Open
FY2024 Q210-QJun 30, 2024Aug 14, 202482Open
FY2024 Q110-QMar 31, 2024May 15, 202493Open
FY202310-KDec 31, 2023Mar 27, 2024263Open

Financial data

313 concepts · 3,317 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial310 concepts · 3,294 facts · Mar 2020 to Jun 2026

  • Net income loss32 · Mar 2020 to Jun 2026
  • Stockholders equity (US GAAP)32 · Mar 2020 to Jun 2026
  • Stock issued during period value share based compensation gross32 · Mar 2020 to Jun 2026
  • Investment income interest31 · Jun 2020 to Jun 2026
  • Operating expenses (US GAAP)31 · Jun 2020 to Jun 2026
  • Operating income loss31 · Jun 2020 to Jun 2026
  • Research and development expense31 · Jun 2020 to Jun 2026
  • Share based compensation31 · Jun 2020 to Jun 2026
  • Cash cash equivalents restricted cash and restricted cash equivalents including disposal group and discontinued operations30 · Sep 2020 to Jun 2026
  • Depreciation30 · Sep 2020 to Jun 2026
  • Increase decrease in accounts payable30 · Sep 2020 to Jun 2026
  • Net cash provided by used in financing activities30 · Sep 2020 to Jun 2026
  • Net cash provided by used in investing activities30 · Sep 2020 to Jun 2026
  • Net cash provided by used in operating activities30 · Sep 2020 to Jun 2026
  • Payments to acquire property plant and equipment30 · Sep 2020 to Jun 2026
  • Cash and cash equivalents at carrying value29 · Jun 2020 to Jun 2026
  • Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect29 · Dec 2020 to Jun 2026
  • General and administrative expense (US GAAP)29 · Jun 2020 to Dec 2025
  • Operating lease right of use asset29 · Dec 2020 to Jun 2026
  • Accounts payable current28 · Dec 2020 to Jun 2026
  • Additional paid in capital28 · Dec 2020 to Jun 2026
  • Assets28 · Dec 2020 to Jun 2026
  • Assets current28 · Dec 2020 to Jun 2026
  • Common stock par or stated value per share28 · Dec 2020 to Jun 2026

KPI3 concepts · 23 facts · Sep 2021 to Jun 2026

  • Clinical Trial Participants18 · Sep 2021 to Mar 2026
  • Median Progression-Free Survival3 · Jun 2026
  • Objective Response Rate2 · Jun 2026

Segments

Figures broken down by business line, region, product or another axis the company reports on.

No segment breakdowns.

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.

Celcuity Inc. (CELC) data · FactIQ